|
1
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000–14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strickaert A, Corbet C, Spinette SA,
Craciun L, Dom G, Andry G, Larsimont D, Wattiez R, Dumont JE, Feron
O and Maenhaut C: Reprogramming of energetic metabolism: Increased
expression and roles of pyruvate carboxylase in papillary thyroid
cancer. Thyroid. 2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou X, Yang X, Sun X, Xu X, Li X, Guo Y,
Wang J, Li X, Yao L, Wang H and Shen L: Effect of PTEN loss on
metabolic reprogramming in prostate cancer cells. Oncol Lett.
17:2856–2866. 2019.PubMed/NCBI
|
|
4
|
Li X, Xu H, Lei T, Yang Y, Jing D, Dai S,
Luo P and Xu Q: A pulsed electromagnetic field protects against
glutamate-induced excitotoxicity by modulating the endocannabinoid
system in HT22 cells. Front Neurosci. 11:422017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dyall SC, Mandhair HK, Fincham REA, Kerr
DM, Roche M and Molina-Holgado F: Distinctive effects of
eicosapentaenoic and docosahexaenoic acids in regulating neural
stem cell fate are mediated via endocannabinoid signalling
pathways. Neuropharmacology. 107:387–395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cinar R, Godlewski G, Liu J, Tam J,
Jourdan T, Mukhopadhyay B, Harvey-White J and Kunos G: Hepatic
cannabinoid-1 receptors mediate diet-induced insulin resistance by
increasingde novosynthesis of long-chain ceramides. Hepatology.
59:143–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sean M. Emery AHL and David A: Gewirtz:
Involvement of the endocannabinoid system in the development and
treatment of breast cancer. Virginia commonwealth univ richmond;
2014
|
|
8
|
Orellana-Serradell O, Poblete CE, Sanchez
C, Castellón EA, Gallegos I, Huidobro C, Llanos MN and Contreras
HR: Proapoptotic effect of endocannabinoids in prostate cancer
cells. Oncol Rep. 33:1599–1608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ligresti A, Bisogno T, Matias I, De
Petrocellis L, Cascio MG, Cosenza V, D'argenio G, Scaglione G,
Bifulco M, Sorrentini I and Di Marzo V: Possible endocannabinoid
control of colorectal cancer growth. Gastroenterology. 125:677–687.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galve-Roperh I, Sánchez C, Cortés ML,
Gómez del Pulgar T, Izquierdo M and Guzmán M: Anti-tumoral action
of cannabinoids: Involvement of sustained ceramide accumulation and
extracellular signal-regulated kinase activation. Nat Med.
6:313–319. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Igal RA: Stearoyl CoA desaturase-1: New
insights into a central regulator of cancer metabolism. Biochim
Biophys Acta. 12:1865–1880. 2016. View Article : Google Scholar
|
|
12
|
Chen L, Ren J, Yang L, Li Y, Fu J, Li Y,
Tian Y, Qiu F, Liu Z and Qiu Y: Stearoyl-CoA desaturase-1 mediated
cell apoptosis in colorectal cancer by promoting ceramide
synthesis. Sci Rep. 6:196652016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Wenes M, Romero P, Huang SC, Fendt
SM and Ho PC: Navigating metabolic pathways to enhance antitumour
immunity and immunotherapy. Nat Rev Clin Oncol. 2019.(Epub ahead of
print). View Article : Google Scholar
|
|
14
|
Mittal S and El-Serag HB: Epidemiology of
HCC: consider the population. J Clin Gastroenterol. 47:S2–S6. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Chen H, Li Y, Li L, Qiu Y and Ren
J: Endocannabinoid and ceramide levels are altered in patients with
colorectal cancer. Oncol Rep. 34:447–454. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y,
Li L and Shen P: Estrogen represses hepatocellular carcinoma (HCC)
growth via inhibiting alternative activation of tumor-associated
macrophages (TAMs). J Biol Chem. 287:40140–40149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH,
Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, et al: Guidelines for
diagnosis and treatment of primary liver cancer in China (2017
Edition). Liver Cancer. 7:235–260. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu J, Gaetani S, Oveisi F, Lo Verme J,
Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di
Giacomo B, Tarzia G and Piomelli D: Oleylethanolamide regulates
feeding and body weight through activation of the nuclear receptor
PPAR-alpha. Nature. 425:90–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bobrov MY, Shevchenko VP, Yudushkin IA,
Rogov SI, Remov MN, Fomina-Ageeva EV, Gretskaya NM, Nagaev IY,
Kuklev DV and Bezuglov VV: Hydrolysis of anandamide and
eicosapentaenoic acid ethanolamide in mouse splenocytes.
Biochemistry. 65:615–619. 2000.PubMed/NCBI
|
|
21
|
Nomura DK, Long JZ, Niessen S, Hoover HS,
Ng SW and Cravatt BF: Monoacylglycerol lipase regulates a fatty
acid network that promotes cancer pathogenesis. Cell. 140:49–61.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morad SA and Cabot MC:
Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer.
13:51–65. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsui H, Yokoyama T, Sekiguchi K, Iijima
D, Sunaga H, Maniwa M, Ueno M, Iso T, Arai M and Kurabayashi M:
Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty
acid-induced lipid accumulation and inhibits apoptosis in cardiac
myocytes. PLoS One. 7:e332832012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Massi P, Valenti M, Vaccani A, Gasperi V,
Perletti G, Marras E, Fezza F, Maccarrone M and Parolaro D:
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the
antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
J Neurochem. 104:1091–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou L, Ding L, Yin P, Lu X, Wang X, Niu
J, Gao P and Xu G: Serum metabolic profiling study of
hepatocellular carcinoma infected with hepatitis B or hepatitis C
virus by using liquid chromatography-mass spectrometry. J Proteome
Res. 11:5433–5442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou
J, Fan W, Li Q, Wang Q, Zhong D and Miao X: Overexpression of
cannabinoid receptors CB1 and CB2 correlates with improved
prognosis of patients with hepatocellular carcinoma. Cancer Genet
Cytogenet. 171:31–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukhopadhyay B, Schuebel K, Mukhopadhyay
P, Cinar R, Godlewski G, Xiong K, Mackie K, Lizak M, Yuan Q,
Goldman D and Kunos G: Cannabinoid receptor 1 promotes
hepatocellular carcinoma initiation and progression through
multiple mechanisms. Hepatology. 61:1615–1626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Louvet A, Teixeira-Clerc F, Chobert MN,
Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A and Lotersztajn
S: Cannabinoid CB2 receptors protect against alcoholic liver
disease by regulating Kupffer cell polarization in mice.
Hepatology. 54:1217–1226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Teixeira-Clerc F, Belot MP, Manin S,
Deveaux V, Cadoudal T, Chobert MN, Louvet A, Zimmer A, Tordjmann T,
Mallat A and Lotersztajn S: Beneficial paracrine effects of
cannabinoid receptor 2 on liver injury and regeneration.
Hepatology. 52:1046–1059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Blázquez C, Casanova ML, Planas A, Gómez
Del Pulgar T, Villanueva C, Fernández-Aceñero MJ, Aragonés J,
Huffman JW, Jorcano JL and Guzmán M: Inhibition of tumor
angiogenesis by cannabinoids. FASEB J. 17:529–531. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hermanson DJ and Marnett LJ: Cannabinoids,
endocannabinoids, and cancer. Cancer Metast Rev. 30:599–612. 2011.
View Article : Google Scholar
|
|
32
|
Ravi J, Sneh A, Shilo K, Nasser MW, Nasser
MW and Ganju RK: FAAH inhibition enhances anandamide mediated
anti-tumorigenic effects in non-small cell lung cancer by
downregulating the EGF/EGFR pathway. Oncotarget. 5:2475–2486. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nomura DK, Lombardi DP, Chang JW, Niessen
S, Ward AM, Long JZ, Hoover HH and Cravatt BF: Monoacylglycerol
lipase exerts dual control over endocannabinoid and fatty acid
pathways to support prostate cancer. Chem Biol. 18:846–856. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cianchi F, Papucci L, Schiavone N, Lulli
M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E,
Romagnani P, et al: Cannabinoid receptor activation induces
apoptosis through tumor necrosis factor α–mediated ceramide de novo
synthesis in colon cancer cells. Clin Cancer Res. 14:7691–7700.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karahatay S, Thomas K, Koybasi S, Senkal
CE, Elojeimy S, Liu X, Bielawski J, Day TA, Gillespie MB, Sinha D,
et al: Clinical relevance of ceramide metabolism in the
pathogenesis of human head and neck squamous cell carcinoma
(HNSCC): Attenuation of C(18)-ceramide in HNSCC tumors correlates
with lymphovascular invasion and nodal metastasis. Cancer Lett.
256:101–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Befeler AS and Di Bisceglie AM:
Hepatocellular carcinoma: Diagnosis and treatment.
Gastroenterology. 122:1609–1619. 2002. View Article : Google Scholar : PubMed/NCBI
|
